High-performance liquid chromatographic determination of the antifungal drug fluconazole in plasma and saliva of human immunodeficiency virus-infected patients.

[1]  M. Gill,et al.  Determination of fluconazole in human serum by solid-phase extraction and reversed-phase high-performance liquid chromatography. , 1992, Therapeutic drug monitoring.

[2]  M. Rinaldi,et al.  Assay of fluconazole by high-performance liquid chromatography with a mixed-phase column , 1992, Antimicrobial Agents and Chemotherapy.

[3]  D. Stevens,et al.  Standardization of a fluconazole bioassay and correlation of results with those obtained by high-pressure liquid chromatography , 1991, Antimicrobial Agents and Chemotherapy.

[4]  J. Beijnen,et al.  Gas chromatographic analysis, with electron capture detection, of the antifungal drug fluconazole in microvolumes of human plasma. , 1991, Journal of pharmaceutical and biomedical analysis.

[5]  H. T. Karnes,et al.  Calibration and validation of linearity in chromatographic biopharmaceutical analysis. , 1991, Journal of pharmaceutical and biomedical analysis.

[6]  D. Debruyne,et al.  Determination of fluconazole in biological fluids by capillary column gas chromatography with a nitrogen detector. , 1988, Journal of pharmaceutical sciences.

[7]  R. van Furth,et al.  A prospective study of the efficacy of fluconazole (UK-49,858) against deep-seated fungal infections. , 1988, The Journal of antimicrobial chemotherapy.

[8]  A. Catanzaro,et al.  Fluconazole Penetration into Cerebrospinal Fluid in Humans , 1988, Journal of clinical pharmacology.

[9]  P. Troke,et al.  Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice , 1985, Antimicrobial Agents and Chemotherapy.